TotalMarketCap

IDEAYA Biosciences

IDYANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.966 B

$30.67 -5.22%

Close of 6 Nov 2026

As of 6 Nov 2026, IDEAYA Biosciences (IDYA) has a market capitalization of $2.97B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$218.7M

#2241 by revenue

Earnings

-$113.7M

Loss-making

Shares outstanding

96,694,575

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #74Telix PharmaceuticalsTLX$3.19B
  2. #75Bausch Health CompaniesBHC$2.99B
  3. #76IDEAYA BiosciencesIDYA$2.97B
  4. #77Vicore Pharma Holding ABVCRE$2.95B
  5. #78XencorXNCR$2.56B

What if IDEAYA Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$292,021.28

Per share 9,521× higher

Bitcoin $1.53T

$15,800.76

Per share 515× higher

Apple $5.02T

$51,872.43

Per share 1,691× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for IDEAYA Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.